Selective 5‐hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

The Hospital Anxiety and Depression Scale

1983 • 42,177 citations

Non-colonic features of irritable bowel syndrome.

1986 • 475 citations

328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over Design

1972 • 470 citations

Controlled treatment trials in the irritable bowel syndrome: A critique

1988 • 392 citations

Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT₃‐receptor antagonist, in patients with irritable bowel syndrome

1993 • 186 citations

Review article: 5‐hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

1992 • 174 citations

GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

1990 • 165 citations

Non-colonic features of irritable bowel syndrome

1986 • 110 citations

A Log-Linear Model for Binary Cross-Over Data

1987 • 52 citations

Irritable Bowel Syndrome (IBS)—Definition and pathophysiology

1987 • 35 citations

5-Hydroxytryptamine and 5-Hydroxytryptamine-3 Receptor Antagonists

1991 • 30 citations

Irritable Bowel Syndrome (IBS)

1986 • 13 citations

The pharmacology of new anxiolytics acting on 5-HT neurones.

1990 • 7 citations

Deleted Work

1955 • 0 citations